CONSEQUENCES OF THE DYT1 MUTATION ON torsinA OLIGOMERIZATION AND DEGRADATION

被引:41
作者
Gordon, K. L. [4 ]
Gonzalez-Alegre, P. [1 ,2 ,3 ,4 ]
机构
[1] Univ Iowa, Carver Coll Med, Dept Neurol, Iowa City, IA 52242 USA
[2] Univ Iowa, Carver Coll Med, Interdisciplinary Grad Program Mol & Cellular Bio, Iowa City, IA 52242 USA
[3] Univ Iowa, Carver Coll Med, Interdisciplinary Grad Program Genet, Iowa City, IA 52242 USA
[4] Univ Iowa, Carver Coll Med, Interdisciplinary Grad Program Neurosci, Iowa City, IA 52242 USA
关键词
dystonia; autophagy; proteasome;
D O I
10.1016/j.neuroscience.2008.09.028
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
DYT1 is the most common inherited dystonia, a neurological syndrome that causes disabling involuntary muscle contractions. This autosomal dominant disease is caused by a glutamic acid deletion near the carboxy-terminus in the protein torsinA. Cell- and animal-based studies have shown how the DYT1 mutation causes mutant torsinA to redistribute from the endoplasmic reticulum to the nuclear envelope, acting through a dominant negative effect over the wild type protein. As a result, the wild type:mutant torsinA expression ratio would be important for disease pathogenesis, and events that influence it, such as a differential degradation process for each protein, might modulate DYT1 pathobiology. The DYT1 mutation also triggers the formation of abnormal intermolecular disulfide bonds in torsinA, although the significance of this finding is unclear. How the protein quality control machinery handles torsinA, and whether this process is affected by its abnormal oligomerization remain unknown. Here, we first explored how the disease-linked mutation influences the catabolic process of human torsinA, demonstrating that the differences in subcellular localization between both forms of torsinA lead to divergences in their degradation pathways and, whereas torsinA is normally recycled through autophagy, the proteasome is also required for the efficient clearance of the mutated form. Subsequently, we determined that the abnormal disulfide bond-dependent oligomerization of mutant torsinA is not a result of its redistribution to the nuclear envelope, but a direct consequence of the mutation. Finally, we established that the presence of disulfide links in mutant torsinA oligomers interfere with their degradation by the proteasome, thus relying on autophagy as the main pathway for clearance. In conclusion, the abnormal subcellular localization and oligomerization of DYT1-linked torsinA influences its catabolic process, opening the door to the modulation of the wild type:mutant torsinA ratio through pharmacological manipulation of protein degradation pathways. (C) 2008 IBRO. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:588 / 595
页数:8
相关论文
共 29 条
[1]   TorsinA: Movement at many levels [J].
Breakefield, XO ;
Kamm, C ;
Hanson, PI .
NEURON, 2001, 31 (01) :9-12
[2]   Autophagy: in sickness and in health [J].
Cuervo, AM .
TRENDS IN CELL BIOLOGY, 2004, 14 (02) :70-77
[3]  
Fahn S, 1998, Adv Neurol, V78, P1
[4]   Two endoplasmic reticulum-associated degradation (ERAD) systems for the novel variant of the mutant dysferlin: ubiquitin/proteasome ERAD(I) and autophagy/lysosome ERAD(II) [J].
Fujita, Eriko ;
Kouroku, Yoriko ;
Isoai, Atsushi ;
Kumagai, Hiromichi ;
Misutani, Akifumi ;
Matsuda, Chie ;
Hayashi, Yukiko K. ;
Momoi, Takashi .
HUMAN MOLECULAR GENETICS, 2007, 16 (06) :618-629
[5]   Dystonia-associated mutations cause premature degradation of torsinA protein and cell-type-specific mislocalization to the nuclear envelope [J].
Giles, Lisa M. ;
Chen, Jue ;
Li, Lian ;
Chin, Lih-Shen .
HUMAN MOLECULAR GENETICS, 2008, 17 (17) :2712-2722
[6]   Silencing primary dystonia: Lentiviral-mediated RNA interference therapy for DYT1 dystonia [J].
Gonzalez-Alegre, P ;
Bode, N ;
Davidson, BL ;
Paulson, HL .
JOURNAL OF NEUROSCIENCE, 2005, 25 (45) :10502-10509
[7]   Aberrant cellular Behavior of mutant torsinA implicates nuclear envelope dysfunction in DYT1 dystonia [J].
Gonzalez-Alegre, P ;
Paulson, HL .
JOURNAL OF NEUROSCIENCE, 2004, 24 (11) :2593-2601
[8]   Toward therapy for DYT1 dystonia: Allele-specific silencing of mutant TorsinA [J].
Gonzalez-Alegre, P ;
Miller, VM ;
Davidson, BL ;
Paulson, HL .
ANNALS OF NEUROLOGY, 2003, 53 (06) :781-787
[9]   The inherited dystonias [J].
Gonzalez-Alegre, Pedro .
SEMINARS IN NEUROLOGY, 2007, 27 (02) :151-158
[10]   Mislocalization to the nuclear envelope: An effect of the dystonia-causing torsinA mutation [J].
Goodchild, RE ;
Dauer, WT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (03) :847-852